Concepedia

Martha A. Ornelas

MA

Statistics

Publications

14

Citations

1K

H-Index

13

Active since

2010

Affiliations

Pfizer (United States)(Current)

Scripps Research Institute

Martha A. Ornelas is an author at Pfizer (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2010–2021

14

Publications

14

C–H Methylation of Heteroarenes Inspired by Radical SAM Methyl Transferase

Jinghan Gui, Qianghui Zhou, Chung‐Mao Pan et al. · Journal of the American Chemical Society · 2014 · 191 citations · Full text

, , +12

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 186 citations

, , +14

Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer

Kevin D. Freeman‐Cook, Robert L. Hoffman, Douglas C. Behenna et al. · Journal of Medicinal Chemistry · 2021 · 117 citations · Full text

, , +12

Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1

Kevin Ryan, Ben Bolaños, Marissa L. Smith et al. · Journal of Biological Chemistry · 2020 · 91 citations · Full text

, , +16

Systematic Structure Modifications of Imidazo[1,2-<i>a</i>]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO)

Angelica Linton, Ping Kang, Martha A. Ornelas et al. · Journal of Medicinal Chemistry · 2011 · 81 citations

, , +16

1–5 of 14